TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case-Control Study.

Mansour SalesiBehrokh ShojaieZiba FarajzadeganNaghmeh SalesiErfan Mohammadi

Published in: Rheumatology and therapy (2021)

A direct and positive correlation between the use of TNF-α blockers and a reduction in the incidence of COVID-19 could suggest the prophylactic role of these drugs in preventing COVID-19 in patients with RA and SpA.

Keyphrases

coronavirus disease
sars cov
rheumatoid arthritis
angiotensin converting enzyme
respiratory syndrome coronavirus
risk factors
disease activity
ankylosing spondylitis